Cost-effectiveness analysis: A tool in the hands of the clinician

被引：2
|
作者：
De Carlo, Marco [1 ]
机构：
[1] Azienda Osped Univ Pisana, Cardiothorac & Vasc Dept, Pisa, Italy
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2019年 / 26卷 / 08期
关键词：
RIVAROXABAN; ASPIRIN; DISEASE;
D O I：
10.1177/2047487318822357
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：855 / 857
页数：3
相关论文
共 50 条
  • [21] Strengthening Cost-Effectiveness Analysis for Public Health Policy
    Russell, Louise B.
    Sinha, Anushua
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2016, 50 (05) : S6 - S12
  • [22] Optimal Control and Cost-Effectiveness Analysis of Cholera with Vaccination
    Tessema, Fikru Shiferaw
    Koya, Purnachandra Rao
    Bole, Boka Kumsa
    JOURNAL OF MATHEMATICS, 2022, 2022
  • [23] Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism
    Coleman, Craig I.
    Limone, Brendan L.
    Bookhart, Brahim K.
    Mody, Samir H.
    Nutescu, Edith A.
    THROMBOSIS RESEARCH, 2014, 133 (05) : 743 - 749
  • [24] Cost-Effectiveness Analysis of the Management of Distal Ureteral Stones in Children
    Chan, Katherine H.
    Whittam, Benjamin M.
    Krambeck, Amy
    Downs, Stephen M.
    Misseri, Rosalia
    Cain, Mark P.
    Bennett, William E.
    UROLOGY, 2019, 127 : 107 - 112
  • [25] Medicare's use of cost-effectiveness analysis for prevention (but not for treatment)
    Chambers, James D.
    Cangelosi, Michael J.
    Neumann, Peter J.
    HEALTH POLICY, 2015, 119 (02) : 156 - 163
  • [26] A Geographically Weighted Cost-effectiveness Analysis of Newborn Cytomegalovirus Screening
    Lantos, Paul M.
    Gantt, Soren
    Janko, Mark
    Dionne, Francois
    Permar, Sallie R.
    Fowler, Karen
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (06):
  • [27] Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis
    Koerkamp, Bas Groot
    Hunink, M. G. Myriam
    Stijnen, Theo
    Hammitt, James K.
    Kuntz, Karen M.
    Weinstein, Milton C.
    MEDICAL DECISION MAKING, 2007, 27 (02) : 101 - 111
  • [28] The Use of Cost-Effectiveness Analysis for Pediatric Immunization in Developing Countries
    Gauvreau, Cindy Low
    Ungar, Wendy J.
    Koehler, Jillian Clare
    Zlotkin, Stanley
    MILBANK QUARTERLY, 2012, 90 (04) : 762 - 790
  • [29] Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand
    Tosanguan, Jiraboon
    Chaiyakunapruk, Nathorn
    ADDICTION, 2016, 111 (02) : 340 - 350
  • [30] Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis
    Soares, Marta O.
    Canto e Castro, Luisa
    PHARMACOECONOMICS, 2012, 30 (12) : 1101 - 1117
12345